Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06919913 · ClinicalTrials.gov registry record · NA
The Effect of Peri-Operative Adjunctive Probiotics on Immunological Markers in Cases of Prosthetic Joint Infection of the Hip and Knee
A NA study of Prosthetic-joint Infection, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 152
- Enrollment target
- 1
- Study location
NCT06919913: Recruiting NA study of Prosthetic-joint Infection, sponsored by NYU Langone Health.
NCT06919913 is a NA study of Prosthetic-joint Infection that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 152 participants, above the 82-participant average among 9 other Prosthetic-joint Infection trials with a reported enrollment target (85% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06919913, a NA study of Prosthetic-joint Infection, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether probiotics in addition to standard of care (SOC) can improve immunological markers following treatment for prosthetic joint infection (PJI). The study aims to determine whether probiotics in addition to SOC decrease immunological markers following treatment for PJI, improve medical and surgical complications and mortality in patients with PJI, and lead to improved gastrointestinal (GI)-specific patient reported outcomes measures (PROMs) in patients with PJI.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Culturelle Digestive Daily Probiotic Capsule
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2025-07-12 |
| Est. Completion | 2027-01-01 |
| Phase | NA |
What NCT06919913 shows while recruiting
NCT06919913 is an interventional study that assigns participants to a tested intervention. The registered 152 participants enrollment target is mid-sized for trials with a published cap, above the 82-participant average among 9 other Prosthetic-joint Infection trials with a reported enrollment target (85% higher).
The record links to 1 condition, with Prosthetic-joint Infection appearing as the primary indexed condition, and to 1 intervention - of which Culturelle Digestive Daily Probiotic Capsule is the first listed.
NCT06919913 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06919913 about?
NCT06919913 is a clinical study titled "The Effect of Peri-Operative Adjunctive Probiotics on Immunological Markers in Cases of Prosthetic Joint Infection of the Hip and Knee". The purpose of this study is to determine whether probiotics in addition to standard of care (SOC) can improve immunological markers following treatment for prosthetic joint infection (PJI). The study aims to determine whether probiotics in addition to SOC decrease immunological markers following tr...
What is the current status of trial NCT06919913?
This trial is currently recruiting. It is a NA study. The enrollment target is 152 participants. The study started on 2025-07-12. Estimated completion is 2027-01-01.
What conditions does trial NCT06919913 study?
This clinical trial studies the following conditions: Prosthetic-joint Infection.
What interventions are being tested in trial NCT06919913?
The interventions under investigation include: Culturelle Digestive Daily Probiotic Capsule (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06919913?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06919913 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prosthetic-joint Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06919913's enrollment target sits among peer trials
152 3rd of 9 higher than 7 of 9 other Prosthetic-joint Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prosthetic-joint Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Real-component Vs All-cement Articulating Spacers for Periprosthetic Knee Infection
RECRUITING · NA
-
Reduction of Bacterial Seeding in Total Shoulder Arthroplasty
RECRUITING · NA
-
Study of Antibiotic Spacer Design to Treat Infection After Hip Replacement
COMPLETED · NA
-
Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty
RECRUITING · Phase 2
-
A Second Trial of the Abbreviated Protocol Two-Stage Exchange
COMPLETED · Phase 2
-
SURGX Antimicrobial Gel Versus Povidone-iodine Skin Incision Prep in Total Shoulder Arthroplasty
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03328078 · 152 participants · Phase 1
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- NCT04458532 · 152 participants · NA
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer
- NCT04858334 · 152 participants · Phase 2
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- NCT04993859 · 152 participants
Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI